Dara Pharma is recognized as Innovative SME

The Ministry of Economy and Competitiveness has recognized Dara Pharma as an innovative enterprise accredited through the “Innovative SME” label. "Innovator SME" or "Intensive SME in R+D+i" is considered to be the SME that in recent years has carried out activities in the field of Research, Technological Development or Technological Innovation (R+D+i).

Obtaining the  ”Innovative SME” label, makes it possible to combine tax deduction for R+D+i and subsidies for people dedicated to R+D+i. Furthermore, it allows to participate in the Innovative Public Purchase and get access to the financing ICO lines (Technological Innovation Funds).

The requirements to be considered an innovative SME are: if the company has received at least one public financing for innovative projects in the past three years; if the company can unilaterally demonstrate that it carries out innovative activity through a patent or motivated binding report; or if the company already has one of the following certifications: Young Innovative Company (JEI), according to AENOR EA0047; innovative small or microenterprise, according to the AENOR Specification EA0047; or the Certification in accordance with UNE 166.002 standard "R+D+i Management Systems".